HCL PHARMA
Timeline
15 events since 2016Board
Filings
Financial
Establishments
201620182020202220242026
The 2026 accounts are due by 31-07-2027.
2026
Annual accounts 2025 filed NBBabbreviated format · 2 days before the deadline
2025
Highest result from 2017 to 2025 net €36,408 ▲514% The operating result of €53,094 and the net result of €36,408 are both a record.
Annual accounts 2024 filed PDFfull format · 14 days before the deadline
2024
Annual accounts 2023 filed PDFfull format · 30 days late
2023
Annual accounts 2022 filed PDFfull format · 18 days before the deadline
changes role from manager to directorDirector discharge: · General meeting of 04-04-20237 points ▸
- General meeting, 04-04-2023
- Power of attorney,
- Director resignation, (manager)
- Director discharge,
- Board rule, 1
- Director appointment, (director (not named in the articles))
- Registered office clause, rue du Jardinet, n°6 boîte 2, 5650 Walcourt
- The deed holds 7 more points.
2022
Equity above €100,000 equity €101,226 ▲3.9% With a profit in every financial year since 2017, equity grows to €101,226.
Annual accounts 2021 filed PDFfull format · 26 days before the deadline
2021
Annual accounts 2020 filed PDFfull format · 21 days before the deadline
2020
Registered in the Peppol Directory Reachable for e-invoices through 0208:0649663933
Annual accounts 2019 filed PDFmicro format · 21 days before the deadline
2019
Annual accounts 2018 filed PDFmicro format · 27 days before the deadline
2018
Annual accounts 2017 filed PDFmicro format · 28 days before the deadline
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank